MO vs PM vs BUD
161 measures in 16 categories, one definition each, computed from filings and market data.
PM76.7
Philip Morris International Inc.
Consumer Defensive · Tobacco
$205.20 +2.51%$319.8B mkt cap
Score DNA
BUD70.5
Anheuser-Busch InBev SA/NV
Consumer Defensive · Beverages - Alcoholic
$82.59 +1.59%$163.3B mkt cap
Score DNA
Price, rebased to 100 three years ago
MO PM BUD · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry (these stocks sit in different industries). n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | MO | PM | BUD |
|---|---|---|---|
| Insider open-market buys, 180d | 1 | 0 | 0 |
| Insider $ bought, 180d | $0.10M | — | — |
| Congress purchases, 180d | 1 | 3 | 0 |
| Last Congress purchase | 2026-09-04 | 2026-06-02 | — |
| 13F net change in holders | +77 | +68 | +69 |
| ETFs adding shares, 30d | 944 | 1,130 | 18 |
| ETFs trimming, 30d | 708 | 823 | 8 |
| Net ETF funds, 30d | +236 | +307 | +10 |
Valuation
16 measures| Measure | MO | PM | BUD |
|---|---|---|---|
| P/E (TTM) | 15.7x | 29.4x | 10.2x |
| PEG (P/E ÷ 3-yr EPS CAGR) | 2.07 | 2.85 | 0.46 |
| Price / sales | 5.7x | 7.5x | 1.3x
80th
|
| Price / book | — | — | 1.7x
40th
|
| Price / tangible book | — | — | — |
| Price / free cash flow | 15.1x | 25.1x | 6.4x
40th
|
| Price / operating cash flow | 14.5x | 22.4x | 5.0x
40th
|
| Enterprise value | $147.6B | $362.9B | $227.7B
100th
|
| EV / sales | 6.7x | 8.5x | 1.9x
80th
|
| EV / EBITDA | 12.6x | 19.4x | 5.4x |
| EV / EBIT | 12.9x | 21.8x | 6.5x |
| EV / free cash flow | 17.8x | 28.5x | 9.0x
20th
|
| Earnings yield | 6.4% | 3.4% | 9.8%
100th
|
| FCF yield | 6.6% | 4.0% | 15.6%
60th
|
| Operating cash flow yield | 6.9% | 4.5% | 19.9%
60th
|
| Graham number (per share) | — | — | $92.66 |
Profitability (TTM)
12 measures| Measure | MO | PM | BUD |
|---|---|---|---|
| Gross margin | 69.9% | 67.5% | 56.5%
80th
|
| EBITDA margin | 53.3% | 44.0% | 34.7%
80th
|
| Operating margin | 50.2% | 37.7% | 32.2%
100th
|
| EBIT margin | 52.4% | 39.2% | 28.4%
80th
|
| Net margin | 36.4% | 25.6% | 13.0%
80th
|
| NOPAT margin | 38.6% | 30.0% | 24.3%
80th
|
| FCF margin | 37.9% | 29.9% | 20.7%
100th
|
| Operating cash flow margin | 39.5% | 33.5% | 26.6%
80th
|
| R&D / revenue | 0.0% | 0.0% | 0.0%
0th
|
| SG&A / revenue | 11.0% | 29.1% | 34.7%
80th
|
| Stock comp / revenue | 0.0% | 0.0% | 0.5%
80th
|
| Effective tax rate | 23.2% | 20.6% | 24.5%
80th
|
Returns on capital
11 measures| Measure | MO | PM | BUD |
|---|---|---|---|
| ROE (on average equity) | — | — | 18.6%
60th
|
| ROA | 24.3% | 15.9% | 7.4%
60th
|
| ROIC | 43.2% | 36.9% | 18.9%
60th
|
| ROCE | 44.8% | 39.9% | 18.8%
80th
|
| Return on tangible assets | 34.9% | 24.4% | 16.2%
80th
|
| Cash ROIC (OCF / invested capital) | 44.2% | 41.3% | 20.6%
60th
|
| Gross profitability (GP / assets) | 44.3% | 42.1% | 31.5%
60th
|
| ROIC, 3-yr average | 37.6% | 36.2% | 9.8%
60th
|
| ROIC, 5-yr average | — | — | 9.0%
80th
|
| ROE, 5-yr average | — | — | 15.6%
80th
|
| Incremental ROIC | 381.1% | 602.2% | 226.2%
100th
|
Growth
17 measures| Measure | MO | PM | BUD |
|---|---|---|---|
| Revenue growth (TTM YoY) | 8.0% | 9.1% | 2.9%
100th
|
| Revenue growth (QoQ) | -1.3% | 10.3% | 4.3%
20th
|
| Revenue CAGR, 3 yr | 1.9% | 8.7% | 6.7%
80th
|
| Revenue CAGR, 5 yr | 0.6% | 7.2% | 6.8%
80th
|
| Gross profit CAGR, 3 yr | 1.1% | 11.2% | 3.9%
80th
|
| Operating income CAGR, 3 yr | -1.8% | 12.8% | 13.3% |
| Net income growth (TTM YoY) | -9.3% | 32.4% | 31.0% |
| Net income CAGR, 3 yr | 5.4% | 10.6% | 22.5% |
| EPS growth (TTM YoY) | -8.6% | 31.9% | 35.4% |
| EPS CAGR, 3 yr | 7.6% | 10.3% | 22.4% |
| EPS CAGR, 5 yr | 14.2% | 4.1% | -0.5% |
| FCF growth (TTM YoY) | -4.9% | 41.5% | 145.2%
100th
|
| FCF CAGR, 3 yr | -1.1% | 19.7% | 19.0%
80th
|
| Operating cash flow CAGR, 3 yr | -0.6% | 18.2% | 10.6%
60th
|
| Book value CAGR, 3 yr | — | — | 15.8%
80th
|
| Dividend CAGR, 3 yr | 1.9% | 2.3% | 14.0%
100th
|
| Sustainable growth rate | — | — | 9.7% |
Margin history & stability
7 measures| Measure | MO | PM | BUD |
|---|---|---|---|
| Gross margin, 3-yr average | 69.6% | 65.8% | 55.8%
80th
|
| Operating margin, 3-yr average | 53.2% | 36.6% | 26.9%
60th
|
| Net margin, 3-yr average | 43.3% | 23.6% | 10.7%
60th
|
| FCF margin, 3-yr average | 41.5% | 26.9% | 13.3%
60th
|
| Revenue stability (0-1) | 0.01 | 0.97 | 0.99
100th
|
| Earnings stability (0-1) | 0.52 | 0.19 | 0.08
60th
|
| Margin stability (0-1) | 0.97 | 0.97 | 0.95
40th
|
Liquidity (latest quarter)
7 measures| Measure | MO | PM | BUD |
|---|---|---|---|
| Cash & short-term investments | $2.4B | $6.0B | $7.9B
100th
|
| Net cash (− = net debt) | −$22.2B | −$43.1B | −$64.4B
0th
|
| Working capital | −$4.3B | −$536.0M | −$11.2B
0th
|
| Current ratio | 0.44 | 0.98 | 0.66
0th
|
| Quick ratio | 0.30 | 0.55 | 0.50
0th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.30 | 0.23 | 0.24
40th
|
| Defensive interval (days) | 258 days | 359 days | 189 days
100th
|
Leverage & solvency (latest quarter)
13 measures| Measure | MO | PM | BUD |
|---|---|---|---|
| Total debt | $24.6B | $49.1B | $72.3B
100th
|
| Debt / equity | — | — | 0.77
60th
|
| Net debt / equity | — | — | 0.69
60th
|
| Debt / assets | 73.6% | 71.9% | 33.1%
60th
|
| Debt / capital | — | — | 43.6%
60th
|
| Debt / EBITDA | 2.11 | 2.62 | 1.70 |
| Net debt / EBITDA | 1.90 | 2.30 | 1.52 |
| Interest coverage (EBIT / interest) | 10.5x | 10.8x | 3.0x
50th
|
| Cash interest coverage | 7.9x | 9.2x | 2.8x
0th
|
| Debt payback (years of OCF) | 2.8 yrs | 3.4 yrs | 2.2 yrs
20th
|
| Liabilities / assets | 107.8% | 109.8% | 53.7%
20th
|
| IS credit model rating | A | B- | BBB |
| Implied credit spread (bps) | 150 | 900 | 275
40th
|
Efficiency
11 measures| Measure | MO | PM | BUD |
|---|---|---|---|
| Asset turnover | 0.67 | 0.62 | 0.57
60th
|
| Fixed asset turnover | 12.45 | 5.12 | 5.32
100th
|
| Inventory turnover | 6.9 | 1.2 | 9.7
100th
|
| Receivables turnover | 80.0 | 8.4 | 24.4
100th
|
| Days sales outstanding | 5 days | 44 days | 15 days
0th
|
| Days inventory outstanding | 53 days | 293 days | 38 days
0th
|
| Days payables outstanding | 32 days | 103 days | 158 days
60th
|
| Cash conversion cycle (days) | 26 days | 233 days | −105 days
0th
|
| Capex / revenue | 1.5% | 3.6% | 5.9%
20th
|
| Capex / depreciation | 1.66 | 0.75 | 0.94
60th
|
| Operating expense ratio | 12.4% | 28.0% | 29.9%
60th
|
Cash flow & earnings quality
7 measures| Measure | MO | PM | BUD |
|---|---|---|---|
| Operating cash flow / net income | 1.08 | 1.31 | 2.04 |
| FCF / net income | 1.04 | 1.17 | 1.59 |
| FCF / operating cash flow | 96.1% | 89.2% | 78.0%
80th
|
| Capex / operating cash flow | 3.9% | 10.8% | 22.0%
20th
|
| Accruals ratio | -2.0% | -5.0% | -7.7%
80th
|
| Sloan accruals ratio | -1.2% | 3.2% | -4.3%
60th
|
| Earnings quality score (0-1) | 1.00 | 1.00 | 0.75 |
Scores & forensic checks
15 measures| Measure | MO | PM | BUD |
|---|---|---|---|
| IS score | 65 | 77 | 71
100th
|
| IS profitability | 80 | 76 | 72
80th
|
| IS growth | 50 | 75 | 60
100th
|
| IS value | 53 | 45 | 76
100th
|
| IS momentum | 64 | 90 | 87
100th
|
| IS risk (safety) | 100 | 100 | 50
40th
|
| IS quality | 74 | 78 | 83
100th
|
| IS balance sheet | 38 | 43 | 44
60th
|
| IS earnings quality | 90 | 75 | 79
80th
|
| IS cash flow | 71 | 82 | 76
100th
|
| Piotroski F-score (0-9) | 7 | 8 | 8
100th
|
| Altman Z-score | 5.2 | 4.4 | 2.2
40th
|
| Beneish M-score | −2.33 | −2.64 | −2.70
100th
|
| Ohlson O-score | −7.02 | −7.29 | −9.27
0th
|
| IS credit score | 74 | 20 | 59
60th
|
Size (TTM)
8 measures| Measure | MO | PM | BUD |
|---|---|---|---|
| Market cap | $125.4B | $319.8B | $163.3B
100th
|
| Revenue | $21.9B | $42.5B | $122.4B
100th
|
| EBITDA | $11.7B | $18.7B | $42.5B
100th
|
| Net income | $8.0B | $10.9B | $16.0B
100th
|
| Free cash flow | $8.3B | $12.7B | $25.4B
100th
|
| Total assets | $33.4B | $68.3B | $218.4B
100th
|
| Shareholders' equity | −$2.7B | −$8.6B | $93.5B
100th
|
| Employees | 5,900 | 84,900 | 136,805
100th
|
Price performance
9 measures| Measure | MO | PM | BUD |
|---|---|---|---|
| 1 day | +1.7% | +2.5% | +1.6% |
| 1 week | +4.8% | +1.9% | +6.8% |
| 1 month | +7.8% | +8.5% | +4.8% |
| 3 months | +0.6% | +6.3% | +2.1% |
| 6 months | +17.1% | +29.9% | +9.0% |
| Year to date | +31.1% | +27.8% | +29.6% |
| 1 year | +15.8% | +29.9% | +37.3% |
| 3 years, cumulative | +106.5% | +140.3% | +55.8% |
| 5 years, cumulative | +121.0% | +161.2% | +58.2% |
Technicals
4 measures| Measure | MO | PM | BUD |
|---|---|---|---|
| RSI 14 | 76.8 | 64.0 | 67.9 |
| From 52-week high | −2.5% | −2.6% | −4.7% |
| From 52-week low | +37.3% | +44.2% | +38.7% |
| Beta | 0.46 | 0.36 | 0.79 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17